Vitor Luis Fagundes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vitor Luis Fagundes has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Julia Arantes Galvão
Federal University of Parana
3 shared publications - Roberto Pontarolo
Universidade Federal do Paraná
3 shared publications - Svetoslav Dimitrov Todorov
University of São Paulo
3 shared publications - Fernanda Stumpf Tonin
Pharmacy and Pharmaceutical Technology Department, Social and Legal Pharmacy Section, University of Granada, Granada, Spain
2 shared publications Marcos Vinício Alves
ProBacLab Laboratório De Microbiologia de Alimentos Departamento De Alimentos e Nutrição Experimental Food Research Center Faculdade de Ciências Farmacêuticas Universidade De São Paulo São Paulo Brasil
2 shared publications- Raul Edison Luna Lazo
Universidad Cientifica del Sur, Lima 15067, Peru
2 shared publications
Latest Publications
- Open Access
- 10 August 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (8) , 1256
LC-QTOF-MS Chemical Characterization, Cytotoxicity, and Antimicrobial Activity of Blue Geopropolis: An Emerging Type of Brazilian Propolis
Background/Objectives: This study characterized blue geopropolis from Melipona quadrifasciata quadrifasciata (southern Brazil) by comparing its chemical composition, cytotoxicity, antimicrobial activity, and coloration mechanisms directly against green and red Apis mellifera propolis under identical experimental conditions. Methods: Ethanolic extracts of blue geopropolis, green, and red propolis were prepared, followed by hexane and chloroform fractionation. Chemical composition was analyzed by LC-qTOF-MS. Cytotoxicity was assessed in L929 fibroblasts, and antimicrobial activity was determined by minimum inhibitory concentration (MIC) assays against bacterial and fungal strains. The blue coloration was investigated using NaOH and FeCl3 treatments to evaluate the possible involvement of phenolic–iron complexes. Results: Fifty-nine compounds were identified across the three samples, revealing several shared phenolic constituents as well as distinctive chemical features. None of the extracts showed activity against Gram-negative bacteria, including Escherichia coli and Pseudomonas aeruginosa (MIC > 1000 µg/mL). In contrast, activity was observed against Gram-positive bacteria, with MIC values ranging from 20.8 to 1000 µg/mL. Among the samples tested, blue geopropolis showed the strongest activity against Gram-positive bacteria. Blue geopropolis exhibited no significant activity against Candida albicans or Candida parapsilosis (MFC > 1000 µg/mL) but showed variable activity against Sporothrix spp. The colorimetric assay indicated that phenolic–iron complexation may contribute to the blue color. Conclusions: Despite its distinct entomological origin, blue geopropolis shared chemical traits with green and red propolis while demonstrating superior Gram-positive antibacterial activity, a higher selectivity index, and potential antifungal applications against Sporothrix spp., highlighting its promise for biotechnological and pharmacological use.
- 10 August 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (8) , 1256
Open AccessLC-QTOF-MS Chemical Characterization, Cytotoxicity, and Antimicrobial Activity of Blue Geopropolis: An Emerging Type of Brazilian Propolis
Background/Objectives: This study characterized blue geopropolis from Melipona quadrifasciata quadrifasciata (southern Brazil) by comparing its chemical composition, cytotoxicity, antimicrobial activity, and coloration mechanisms directly against green and red Apis mellifera propolis under identical experimental conditions. Methods: Ethanolic extracts of blue geopropolis, green, and red propolis were prepared, followed by hexane and chloroform fractionation. Chemical composition was analyzed by LC-qTOF-MS. Cytotoxicity was assessed in L929 fibroblasts, and antimicrobial activity was determined by minimum inhibitory concentration (MIC) assays against bacterial and fungal strains. The blue coloration was investigated using NaOH and FeCl3 treatments to evaluate the possible involvement of phenolic–iron complexes. Results: Fifty-nine compounds were identified across the three samples, revealing several shared phenolic constituents as well as distinctive chemical features. None of the extracts showed activity against Gram-negative bacteria, including Escherichia coli and Pseudomonas aeruginosa (MIC > 1000 µg/mL). In contrast, activity was observed against Gram-positive bacteria, with MIC values ranging from 20.8 to 1000 µg/mL. Among the samples tested, blue geopropolis showed the strongest activity against Gram-positive bacteria. Blue geopropolis exhibited no significant activity against Candida albicans or Candida parapsilosis (MFC > 1000 µg/mL) but showed variable activity against Sporothrix spp. The colorimetric assay indicated that phenolic–iron complexation may contribute to the blue color. Conclusions: Despite its distinct entomological origin, blue geopropolis shared chemical traits with green and red propolis while demonstrating superior Gram-positive antibacterial activity, a higher selectivity index, and potential antifungal applications against Sporothrix spp., highlighting its promise for biotechnological and pharmacological use.
- 8 June 2026
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 70 (11) , e70523
Influence of Culturing Temperature on Bacteriocin Production and Safety Behavior on Bacteriocinogenic cocci With Antimicrobial and Probiotic Potential
The selection of novel probiotic candidates requires rigorous evaluation of safety and functional properties. This study aimed to assess safety, bacteriocin production and probiotic potential of four bacterial strains isolated from artisanal cheeses: Enterococcus faecium ST02JL and ST03JL, Lactococcus garvieae ST04JL, and Staphylococcus epidermidis ST0409KOC. Experiments were conducted at 37°C and 39°C to simulate physiological and thermal stress conditions. All strains were phenotypically safe, negative for gelatinase, hemolytic activity, and biogenic amine production, featured absence of virulence factors and antibiotic resistance genes. The isolates exhibited resilience to simulated gastrointestinal conditions and produced predominant L(+)‐lactic acid. We evidenced the thermal modulation of bacteriocin activity; S. epidermidis showed a four‐fold increase in anti‐ Listeria activity at 39°C. Resistance to vancomycin was dependent on culturing temperature. Our results demonstrate that the studied strains are safe for use in the dairy industry. Our findings confirmed that, under thermal stress, the biopreservative traits of S. epidermidis ST0409KOC are highly inducible.
- 8 June 2026
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 70 (11) , e70523
Influence of Culturing Temperature on Bacteriocin Production and Safety Behavior on Bacteriocinogenic cocci With Antimicrobial and Probiotic Potential
The selection of novel probiotic candidates requires rigorous evaluation of safety and functional properties. This study aimed to assess safety, bacteriocin production and probiotic potential of four bacterial strains isolated from artisanal cheeses: Enterococcus faecium ST02JL and ST03JL, Lactococcus garvieae ST04JL, and Staphylococcus epidermidis ST0409KOC. Experiments were conducted at 37°C and 39°C to simulate physiological and thermal stress conditions. All strains were phenotypically safe, negative for gelatinase, hemolytic activity, and biogenic amine production, featured absence of virulence factors and antibiotic resistance genes. The isolates exhibited resilience to simulated gastrointestinal conditions and produced predominant L(+)‐lactic acid. We evidenced the thermal modulation of bacteriocin activity; S. epidermidis showed a four‐fold increase in anti‐ Listeria activity at 39°C. Resistance to vancomycin was dependent on culturing temperature. Our results demonstrate that the studied strains are safe for use in the dairy industry. Our findings confirmed that, under thermal stress, the biopreservative traits of S. epidermidis ST0409KOC are highly inducible.
- Open Access
Not Just an Aroma Compound: Expanding Perspectives on Diacetyl in Food Systems and Human Health
Diacetyl has been a known key volatile compound for almost one century, a metabolite naturally produced by different microorganisms during fermentation processes, with traditional applications in food products preparations. Since its discovery, diacetyl has been recognized and actively explored regarding its buttery aroma, which is beneficial for a variety of fermented dairy foods. It is primarily synthesized by lactic acid bacteria (LAB) and other microbial groups through citrate metabolism, a pathway that is strain-dependent and strongly influenced by environmental conditions. Moreover, beyond its sensory relevance, diacetyl has attracted increasing scientific attention because of its antimicrobial activity, including synergistic interactions with bacteriocins and other microbial metabolites, which may enhance food preservation and biotechnological strategies. In contrast, its presence merits attention and needs to be carefully monitored in alcoholic beverages such as beer and wine, where excessive accumulation may compromise product quality. Some studies suggested that diacetyl may have negative health influences and presents safety concerns, as inhalation exposure was associated with pulmonary toxicity and occupational diseases, and was even suggested as one of the risk factors in electronic cigarettes. Emerging studies suggest that diacetyl may exhibit pharmacological potential, including antioxidant, antifungal, and even neuroprotective properties, although research is still in early stages and merits deeper scientific evaluation. Considering its dual nature, beneficial and harmful, this review provides an overview of diacetyl’s properties, safety considerations, and promising applications in biotechnology, biomedicine, and fermented food systems, but with a focus on potential industrial and health hazards. In the current review, we have presented evidence for diacetyl’s beneficial properties and discussed its hazards.
Open AccessNot Just an Aroma Compound: Expanding Perspectives on Diacetyl in Food Systems and Human Health
Diacetyl has been a known key volatile compound for almost one century, a metabolite naturally produced by different microorganisms during fermentation processes, with traditional applications in food products preparations. Since its discovery, diacetyl has been recognized and actively explored regarding its buttery aroma, which is beneficial for a variety of fermented dairy foods. It is primarily synthesized by lactic acid bacteria (LAB) and other microbial groups through citrate metabolism, a pathway that is strain-dependent and strongly influenced by environmental conditions. Moreover, beyond its sensory relevance, diacetyl has attracted increasing scientific attention because of its antimicrobial activity, including synergistic interactions with bacteriocins and other microbial metabolites, which may enhance food preservation and biotechnological strategies. In contrast, its presence merits attention and needs to be carefully monitored in alcoholic beverages such as beer and wine, where excessive accumulation may compromise product quality. Some studies suggested that diacetyl may have negative health influences and presents safety concerns, as inhalation exposure was associated with pulmonary toxicity and occupational diseases, and was even suggested as one of the risk factors in electronic cigarettes. Emerging studies suggest that diacetyl may exhibit pharmacological potential, including antioxidant, antifungal, and even neuroprotective properties, although research is still in early stages and merits deeper scientific evaluation. Considering its dual nature, beneficial and harmful, this review provides an overview of diacetyl’s properties, safety considerations, and promising applications in biotechnology, biomedicine, and fermented food systems, but with a focus on potential industrial and health hazards. In the current review, we have presented evidence for diacetyl’s beneficial properties and discussed its hazards.
- 24 November 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 115
Water-in-water emulsions as versatile platforms for controlled drug release systems: A scoping review
- 24 November 2025
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 115
Water-in-water emulsions as versatile platforms for controlled drug release systems: A scoping review
- Open Access
- 17 November 2025
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 70 (1) , e70326
An Integrated Engineering Approach to Creating Health‐Modulating Postbiotics
Postbiotics have emerged as a promising alternative to live probiotics, offering comparable health benefits while overcoming challenges related to safety, stability, and shelf life. This review provides a comprehensive overview of the current state of postbiotic research, beginning with updated definitions and the rationale for transitioning from live microbial formulations to inanimate postbiotics. We examine the diverse mechanisms by which postbiotics modulate host physiology, including enhancement of epithelial barrier function, immunomodulation, systemic metabolic regulation, neuroactive effects, anti‐inflammatory activities, and anticancer properties. Detailed discussions highlight how bioactive components—such as bacteriocins, exopolysaccharides (EPS), short‐chain fatty acids (SCFA), and specific proteins (e.g., Amuc_1100 and P9 from Akkermansia muciniphila )—mediate these effects through complex cellular signaling pathways and host‐microbe interactions. Furthermore, we review the antimicrobial potential of postbiotic formulations, emphasizing their role in controlling pathogenic and spoilage microorganisms. Various methods for microbial inactivation are discussed, ranging from conventional thermal techniques (e.g., pasteurization and ohmic heating) to non‐thermal approaches (e.g., ultrasonication, ionizing radiation, and ultraviolet light), as well as innovative hybrid methods that combine chemical, physical, and enzymatic treatments. These strategies not only ensure the complete inactivation of live microorganisms but also preserve the integrity and bioactivity of postbiotic compounds. Comparative analyses of live probiotics versus postbiotics reveal that inactivated formulations can deliver similar or even enhanced health benefits, with superior safety profiles and improved quality control. The review concludes by addressing current challenges in standardizing postbiotic definitions and production processes and by outlining future research directions necessary to unlock their full potential in clinical, nutritional, and biotechnological applications.
- 17 November 2025
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 70 (1) , e70326
Open AccessAn Integrated Engineering Approach to Creating Health‐Modulating Postbiotics
Postbiotics have emerged as a promising alternative to live probiotics, offering comparable health benefits while overcoming challenges related to safety, stability, and shelf life. This review provides a comprehensive overview of the current state of postbiotic research, beginning with updated definitions and the rationale for transitioning from live microbial formulations to inanimate postbiotics. We examine the diverse mechanisms by which postbiotics modulate host physiology, including enhancement of epithelial barrier function, immunomodulation, systemic metabolic regulation, neuroactive effects, anti‐inflammatory activities, and anticancer properties. Detailed discussions highlight how bioactive components—such as bacteriocins, exopolysaccharides (EPS), short‐chain fatty acids (SCFA), and specific proteins (e.g., Amuc_1100 and P9 from Akkermansia muciniphila )—mediate these effects through complex cellular signaling pathways and host‐microbe interactions. Furthermore, we review the antimicrobial potential of postbiotic formulations, emphasizing their role in controlling pathogenic and spoilage microorganisms. Various methods for microbial inactivation are discussed, ranging from conventional thermal techniques (e.g., pasteurization and ohmic heating) to non‐thermal approaches (e.g., ultrasonication, ionizing radiation, and ultraviolet light), as well as innovative hybrid methods that combine chemical, physical, and enzymatic treatments. These strategies not only ensure the complete inactivation of live microorganisms but also preserve the integrity and bioactivity of postbiotic compounds. Comparative analyses of live probiotics versus postbiotics reveal that inactivated formulations can deliver similar or even enhanced health benefits, with superior safety profiles and improved quality control. The review concludes by addressing current challenges in standardizing postbiotic definitions and production processes and by outlining future research directions necessary to unlock their full potential in clinical, nutritional, and biotechnological applications.
- 20 October 2025
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 69 (23) , e70268
Bacteriocinogenic Pediococcus acidilactici ST41VF Isolated From Bulgaria Feta Cheese: Probiotic Potential, Biopreservative Properties, and Safety Evaluation
Dairy products are traditional sources of potentially bactriocinogenic and probiotic microorganisms, especially lactic acid bacteria (LAB). This study aimed to isolate bacteriocin‐producing LAB from Bulgarian feta cheese and assess their biopreservative, probiotic potential, and safety. Pediococcus acidilactici ST41VF was isolated and shown to inhibit multiple Listeria monocytogenes strains through the production of bacteriocin. This bacteriocin remained stable across a range of pH levels, temperatures, and chemical exposures relevant to pharmaceutical contexts. The highest bacteriocin concentration (6400 AU/mL) occurred during the stationary growth phase. Safety assessments revealed that ST41VF does not produce biogenic amines or gelatinase, lacks proteolytic and mucin‐degrading activity, and exhibits γ‐hemolytic behavior. It tolerated gastrointestinal simulations, thriving in various pH levels, salt concentrations, and ox‐bile. The strain produced 4.998 g/L of d ‐lactic acid and 7.110 g/L of l ‐lactic acid, a relevant information regarding potential negative effects of d ‐lacid acid. Considering its robust antimicrobial activity, resilience, and safety profile, P. acidilactici ST41VF demonstrates strong potential as a biopreservative in food systems and a probiotic candidate for therapeutic applications.
- 20 October 2025
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 69 (23) , e70268
Bacteriocinogenic Pediococcus acidilactici ST41VF Isolated From Bulgaria Feta Cheese: Probiotic Potential, Biopreservative Properties, and Safety Evaluation
Dairy products are traditional sources of potentially bactriocinogenic and probiotic microorganisms, especially lactic acid bacteria (LAB). This study aimed to isolate bacteriocin‐producing LAB from Bulgarian feta cheese and assess their biopreservative, probiotic potential, and safety. Pediococcus acidilactici ST41VF was isolated and shown to inhibit multiple Listeria monocytogenes strains through the production of bacteriocin. This bacteriocin remained stable across a range of pH levels, temperatures, and chemical exposures relevant to pharmaceutical contexts. The highest bacteriocin concentration (6400 AU/mL) occurred during the stationary growth phase. Safety assessments revealed that ST41VF does not produce biogenic amines or gelatinase, lacks proteolytic and mucin‐degrading activity, and exhibits γ‐hemolytic behavior. It tolerated gastrointestinal simulations, thriving in various pH levels, salt concentrations, and ox‐bile. The strain produced 4.998 g/L of d ‐lactic acid and 7.110 g/L of l ‐lactic acid, a relevant information regarding potential negative effects of d ‐lacid acid. Considering its robust antimicrobial activity, resilience, and safety profile, P. acidilactici ST41VF demonstrates strong potential as a biopreservative in food systems and a probiotic candidate for therapeutic applications.
- Open Access
- 11 May 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (5) , 638
Safety Profile of Gestrinone: A Systematic Review
Background: Gestrinone is a synthetic hormone derived from 19-nortestosterone, exhibiting androgenic, anabolic, anti-progestogenic, and antiestrogenic effects. Gestrinone subcutaneous implants have been used “off label” for aesthetic purposes due to their anabolic action, promoting accelerated metabolism and muscle gain. Objective: Our goal is to conduct a systematic review focused exclusively on identifying the safety profile of gestrinone use, without addressing efficacy. Methods: This systematic review was performed according to the Joanna Briggs Institute and Cochrane Collaboration recommendations and is reported following the Preferred Reporting Items for Systematic Reviews and Network Meta-Analyses. This article’s searches were carried out in the PubMed, Embase, and Web of Science databases. Results: A total of 32 articles were included in this study. The reported adverse events associated with the use of gestrinone were amenorrhea (41.4% of cases), acne, seborrhea (42.7% of reports), decreased libido (26.5%), and hot flushes (24.2%). Other nonspecific symptoms such as hoarseness and cramps were also fairly reported (3.5% and 18.6%, respectively). Other reported effects were associated with breast size reduction (23.7% of patients) and increased transaminases (15.1%). Most studies (40%, n = 24 studies) found significant weight gain (ranging from 0.9 to 8 kg per patient). Abnormalities in bone mineral density were reported in four studies. Conclusions: The evidence remains insufficient to fully understand the risks of gestrinone uses associated with its widespread, unregulated use. Thus, further standardized studies and regulatory oversight to ensure patient safety are needed to mitigate potential health risks.
- 11 May 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (5) , 638
Open AccessSafety Profile of Gestrinone: A Systematic Review
Background: Gestrinone is a synthetic hormone derived from 19-nortestosterone, exhibiting androgenic, anabolic, anti-progestogenic, and antiestrogenic effects. Gestrinone subcutaneous implants have been used “off label” for aesthetic purposes due to their anabolic action, promoting accelerated metabolism and muscle gain. Objective: Our goal is to conduct a systematic review focused exclusively on identifying the safety profile of gestrinone use, without addressing efficacy. Methods: This systematic review was performed according to the Joanna Briggs Institute and Cochrane Collaboration recommendations and is reported following the Preferred Reporting Items for Systematic Reviews and Network Meta-Analyses. This article’s searches were carried out in the PubMed, Embase, and Web of Science databases. Results: A total of 32 articles were included in this study. The reported adverse events associated with the use of gestrinone were amenorrhea (41.4% of cases), acne, seborrhea (42.7% of reports), decreased libido (26.5%), and hot flushes (24.2%). Other nonspecific symptoms such as hoarseness and cramps were also fairly reported (3.5% and 18.6%, respectively). Other reported effects were associated with breast size reduction (23.7% of patients) and increased transaminases (15.1%). Most studies (40%, n = 24 studies) found significant weight gain (ranging from 0.9 to 8 kg per patient). Abnormalities in bone mineral density were reported in four studies. Conclusions: The evidence remains insufficient to fully understand the risks of gestrinone uses associated with its widespread, unregulated use. Thus, further standardized studies and regulatory oversight to ensure patient safety are needed to mitigate potential health risks.
- Open Access
- 18 November 2024
- Published by Universidade Federal do Parana in Archives of Veterinary Science
- Vol. 29 (4)
Physicochemical and Microbiological Profile of Melipona bicolor Honey
Stingless bee honey has been attracting interest among consumers owing to its wide variety, sensorial characteristics, therapeutic properties and high added value. Several studies have been carried out through native bee honey, however, studies around Melipona bicolor honey - a rare species remain scarce. Accordingly, the aim of this research was to evaluate the physical-chemical and microbiological profile of Melipona bicolor honey in accordance with current legislation in Brazil. Hence, honey from the Melipona bicolor bee was collected in three different meliponaries in the Metropolitan region of Curitiba-PR and evaluated for moisture content, reducing sugars, total sugars, apparent sucrose, pH, water activity and hydroxymethylfurfural (HMF), aerobic mesophilic count, total and thermotolerant coliforms most likely number, and yeast and mold counts. The average result for moisture content was 24.8%, reducing sugars 62.96%, total sugars 65.6% and apparent sucrose 2.6%, pH 2.95 and water activity 0.67. No significant amounts of HMF were detected in the honey from the three properties analyzed. The results of counting aerobic mesophilic bacteria, total and thermotolerant coliforms and counting molds and yeasts, together with the results of analyzing physical-chemical parameters, indicated that the M. bicolor honey analyzed in this study complies with the Identity Standards and Quality imposed by State Legislation for Meliponiculture, therefore, it is suitable for consumption and ready for sale.
- 18 November 2024
- Published by Universidade Federal do Parana in Archives of Veterinary Science
- Vol. 29 (4)
Open AccessPhysicochemical and Microbiological Profile of Melipona bicolor Honey
Stingless bee honey has been attracting interest among consumers owing to its wide variety, sensorial characteristics, therapeutic properties and high added value. Several studies have been carried out through native bee honey, however, studies around Melipona bicolor honey - a rare species remain scarce. Accordingly, the aim of this research was to evaluate the physical-chemical and microbiological profile of Melipona bicolor honey in accordance with current legislation in Brazil. Hence, honey from the Melipona bicolor bee was collected in three different meliponaries in the Metropolitan region of Curitiba-PR and evaluated for moisture content, reducing sugars, total sugars, apparent sucrose, pH, water activity and hydroxymethylfurfural (HMF), aerobic mesophilic count, total and thermotolerant coliforms most likely number, and yeast and mold counts. The average result for moisture content was 24.8%, reducing sugars 62.96%, total sugars 65.6% and apparent sucrose 2.6%, pH 2.95 and water activity 0.67. No significant amounts of HMF were detected in the honey from the three properties analyzed. The results of counting aerobic mesophilic bacteria, total and thermotolerant coliforms and counting molds and yeasts, together with the results of analyzing physical-chemical parameters, indicated that the M. bicolor honey analyzed in this study complies with the Identity Standards and Quality imposed by State Legislation for Meliponiculture, therefore, it is suitable for consumption and ready for sale.
- Open Access
- 13 September 2024
- Published by Springer Nature in Cureus
- Vol. 16 (9)
The Efficacy and Safety of Antifungal Agents for Managing Oral Candidiasis in Oncologic Patients: A Systematic Review With Network Meta-Analysis
This study aimed at synthesizing the available evidence on the comparative safety and efficacy of antifungal agents for preventing or treating oral candidiasis (OC) in oncologic patients. A systematic review following international recommendations was performed (PROSPERO CRD42024507745). A comprehensive search was conducted in PubMed, Scopus, and Web of Science (Feb 2024) to retrieve randomized controlled trials evaluating the clinical effects of antifungal agents in the management of OC in this vulnerable population. Network meta-analyses were performed to evaluate the most prevalent outcomes, with findings reported as odds ratios (ORs) with 95% confidence intervals (CIs). Overall, 24 trials were included, of which 10 addressed OC treatment and 14 disease prophylaxis (n=3449 patients). Fluconazole had the most significant rates of clinical cure when compared to placebo (OR 0.09 [95% CI 0.01-0.69]), amphotericin B (0.21 [95% CI 0.07-0.65]) and itraconazole (OR 0.58 [95% CI 0.34-0.99]); ketoconazole was also superior to placebo for this outcome (OR 0.10 [95% CI 0.03, 0.36]). All antifungal agents presented significantly higher rates of prophylaxis success compared to the absence of an active agent. While these therapies were generally considered safe, only four studies provided data on adverse events, primarily related to gastrointestinal issues. In oncologic patients, azoles (fluconazole, ketoconazole) should be used as a first-line approach for OC treatment. The selection of antifungal agents for disease prophylaxis should consider, among others, patients’ clinical characteristics and preferences. Economic and quality of life-related outcomes should be further addressed in future studies.
- 13 September 2024
- Published by Springer Nature in Cureus
- Vol. 16 (9)
Open AccessThe Efficacy and Safety of Antifungal Agents for Managing Oral Candidiasis in Oncologic Patients: A Systematic Review With Network Meta-Analysis
This study aimed at synthesizing the available evidence on the comparative safety and efficacy of antifungal agents for preventing or treating oral candidiasis (OC) in oncologic patients. A systematic review following international recommendations was performed (PROSPERO CRD42024507745). A comprehensive search was conducted in PubMed, Scopus, and Web of Science (Feb 2024) to retrieve randomized controlled trials evaluating the clinical effects of antifungal agents in the management of OC in this vulnerable population. Network meta-analyses were performed to evaluate the most prevalent outcomes, with findings reported as odds ratios (ORs) with 95% confidence intervals (CIs). Overall, 24 trials were included, of which 10 addressed OC treatment and 14 disease prophylaxis (n=3449 patients). Fluconazole had the most significant rates of clinical cure when compared to placebo (OR 0.09 [95% CI 0.01-0.69]), amphotericin B (0.21 [95% CI 0.07-0.65]) and itraconazole (OR 0.58 [95% CI 0.34-0.99]); ketoconazole was also superior to placebo for this outcome (OR 0.10 [95% CI 0.03, 0.36]). All antifungal agents presented significantly higher rates of prophylaxis success compared to the absence of an active agent. While these therapies were generally considered safe, only four studies provided data on adverse events, primarily related to gastrointestinal issues. In oncologic patients, azoles (fluconazole, ketoconazole) should be used as a first-line approach for OC treatment. The selection of antifungal agents for disease prophylaxis should consider, among others, patients’ clinical characteristics and preferences. Economic and quality of life-related outcomes should be further addressed in future studies.
- Open Access
- 20 February 2024
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- Vol. 12, 1-10
Mel de abelhas sem ferrão no Brasil: análise bibliométrica e revisão sistemática
Introduction: The honey from stingless bees (SB) is distinguished from honey from Apis mellifera bees, by unique sensory attribute, characteristics such as sweet-sour flavor and fluid viscosity, arousing increased consumer interest. Nevertheless, in recent years the number of scientific productions related to the subject has increased, it is necessary that the published articles are replicable. Objective: To fill important gaps about SB honey in Brazil, considering the structuring and possibility of replication ofavailable studies, as well as the observation of physicochemical and microbiological characteristics of the product in order to base a national legislation. Method: The nine steps described in Methodi Ordinatio were followed. The search for articles was made in SciELO, ScienceDirect, Scopus and Web of Science platforms, using the keywords: “honey from stingless bees”, “meliponiculture”, “physicochemical characteristics” and “microbiological properties”. The content of 18 articles was analyzed. Results: Based on this literature survey, Brazilian SB honey from less than 31 of the species was evaluated. Therefore, there is a large number of species to be explored for their physicochemical, microbiological characteristics as well as antioxidant/microbial potential of their honeys from many Brazilian regions. Besides, it was observed very large variations in the physicochemical characteristics of the products coming from different species and productive regions. Conclusions: The standardization of a national legislation destined to the SB honey can only be established from deep studies, performed with each Brazilian species, providing more safety to the consumer.
- 20 February 2024
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- Vol. 12, 1-10
Open AccessMel de abelhas sem ferrão no Brasil: análise bibliométrica e revisão sistemática
Introduction: The honey from stingless bees (SB) is distinguished from honey from Apis mellifera bees, by unique sensory attribute, characteristics such as sweet-sour flavor and fluid viscosity, arousing increased consumer interest. Nevertheless, in recent years the number of scientific productions related to the subject has increased, it is necessary that the published articles are replicable. Objective: To fill important gaps about SB honey in Brazil, considering the structuring and possibility of replication ofavailable studies, as well as the observation of physicochemical and microbiological characteristics of the product in order to base a national legislation. Method: The nine steps described in Methodi Ordinatio were followed. The search for articles was made in SciELO, ScienceDirect, Scopus and Web of Science platforms, using the keywords: “honey from stingless bees”, “meliponiculture”, “physicochemical characteristics” and “microbiological properties”. The content of 18 articles was analyzed. Results: Based on this literature survey, Brazilian SB honey from less than 31 of the species was evaluated. Therefore, there is a large number of species to be explored for their physicochemical, microbiological characteristics as well as antioxidant/microbial potential of their honeys from many Brazilian regions. Besides, it was observed very large variations in the physicochemical characteristics of the products coming from different species and productive regions. Conclusions: The standardization of a national legislation destined to the SB honey can only be established from deep studies, performed with each Brazilian species, providing more safety to the consumer.